CD47在卵巢癌进展中的生物作用

Linan Xing1, Zhao Wang2, Yue Feng2

  • 1Department of Gynecology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, People's Republic of China.

概括

卵巢癌在治疗后经常复发. 针对CD47免疫检查点显示出新免疫疗法的前景,为患有这种致命癌症的患者提供希望.